# DESCRIPTION

- claim benefit of provisional application

## BACKGROUND OF THE INVENTION

- introduce coccidiosis disease
- describe life cycle of Eimeria parasite
- discuss economic problem of coccidiosis
- limitations of coccidiostat drugs
- motivate vaccine development
- describe native antigens from gametocyte stages
- characterize antigens at molecular level
- discuss previous research on subunit vaccine
- limitations of previous vaccine approaches
- summarize state of the art

## SUMMARY OF THE INVENTION

- introduce nucleic acid encoding Eimeria maxima gametocyte antigens

## DETAILED DESCRIPTION OF THE INVENTION

- introduce isolated nucleic acid
- define 56 kDa polypeptide from Gametocytes of Eimeria maxima
- describe homologs of the polypeptide
- specify nucleotide sequence identity
- describe vector comprising isolated nucleic acid
- specify plasmid as vector
- describe host cell comprising vector
- specify host cell types
- introduce transformed cell
- describe method of producing recombinant 56 kDa polypeptide
- introduce vaccine against Eimeria
- describe vaccine composition
- introduce 230 kDa sporozoite/merozoite antigen
- describe isolation and sequencing of 230 kDa antigen
- introduce additional antigens
- describe method of immunizing a subject
- specify administration methods
- introduce fertilized egg inoculated with vaccine
- describe isolated nucleic acid encoding 82 kDa polypeptide
- define nucleic acid embodiments
- describe vector embodiments
- describe host cell embodiments
- describe transformed cell embodiments
- describe method of producing recombinant polypeptide
- describe vaccine embodiments
- describe method of immunizing subject
- describe fertilized egg embodiments
- describe recombinant polypeptide embodiments
- describe additional protein embodiments
- describe administration methods
- describe vaccine composition
- describe immunization methods
- describe homologous sequences
- define homology
- describe hybridization conditions
- describe functionally equivalent sequences
- describe coding sequences
- describe methods for isolating sequences
- describe homologous polypeptides
- define biologically active
- describe portions of polypeptides
- describe deletions, insertions, and substitutions
- describe cloning and sequencing of antigens
- describe expression of recombinant antigens
- describe vaccine composition
- describe production of gametocytes
- describe cloning and sequencing of antigens

### EXPERIMENTAL DETAILS

- Purify Eimeria maxima gametocytes on a large scale
- Incubate intestinal pieces with hyaluronidase
- Filter and collect gametocytes
- Freeze and thaw gametocytes
- Extract proteins from gametocytes
- Isolate 56 and 82 kDa gametocyte antigens using monoclonal antibody
- Perform two-dimensional gel electrophoresis of APGA
- Identify and sequence 56 and 82 kDa antigens
- Sequence amino-terminus and internal tryptic peptides
- Clone genes encoding 56 and 82 kDa antigens using RACE PCR
- Sequence full-length genes and analyze
- Perform Southern and Northern blotting using cloned probes
- Express recombinant 56 and 82 kDa antigens in E. coli
- Analyze recombinant proteins using immunoblotting
- Identify homology of 56 kDa antigen with 30 kDa antigen from oocysts
- Express and analyze gam 56, a 56 kDa gametocyte antigen
- Construct expression vectors and express proteins
- Purify and analyze recombinant proteins
- Immunize chickens with recombinant proteins and analyze sera
- Challenge immunized chickens with E. maxima and analyze oocyst output
- Express and analyze a recombinant fragment of the 250 kDa a sexual stage protein
- Purify and analyze the expressed protein and perform immunogenicity trials

## Example 12

- describe oocyst wall formation in Eimeria
- identify tyrosine-rich regions in proteins
- analyze protein composition of oocyst wall
- discuss implications for oocyst wall structure

